APO Research
Talk to an analyst

APO RESEARCH · REPORT

Digital Insomnia Therapeutics

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Digital Insomnia Therapeutics Market Analysis and Forecast 2026-2032

11 April 2026225 pages

Choose your research edition.

Industry ResearchDigital Insomnia Therapeutics Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Digital Insomnia Therapeutics Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Digital Insomnia Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Digital Insomnia Therapeutics Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Digital Insomnia Therapeutics Market Analysis and Forecast 2026-2032225 pages · $4,950 USD

Market perspective

The global Digital Insomnia Therapeutics market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Digital Insomnia Therapeutics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Digital Insomnia Therapeutics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Digital Insomnia Therapeutics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Digital Insomnia Therapeutics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Digital Insomnia Therapeutics include Headspace Inc, Big Health, Calm, Nox Health, Pear Therapeutics, OPTT Inc, SilverCloud, Curv Health and Bodymatter Inc, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Digital Insomnia Therapeutics, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Digital Insomnia Therapeutics, also provides the revenue of main regions and countries. Of the upcoming market potential for Digital Insomnia Therapeutics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Digital Insomnia Therapeutics revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Digital Insomnia Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Digital Insomnia Therapeutics revenue, projected growth trends, production technology, application and end-user industry.

Digital Insomnia Therapeutics Segment by Company

Headspace Inc

Big Health

Calm

Nox Health

Pear Therapeutics

OPTT Inc

SilverCloud

Curv Health

Bodymatter Inc

PrimeNap

Digital Insomnia Therapeutics Segment by Type

Sleep Tracking App

Relaxation and Meditation Apps

CBT-I

Others

Digital Insomnia Therapeutics Segment by Application

Medical

Household

Digital Insomnia Therapeutics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Digital Insomnia Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Digital Insomnia Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Digital Insomnia Therapeutics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Digital Insomnia Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Digital Insomnia Therapeutics company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Digital Insomnia Therapeutics revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Digital Insomnia Therapeutics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Sleep Tracking App Major Player Table 3. Relaxation and Meditation Apps Major Player Table 4. CBT-I Major Player Table 5. Others Major Player Table 6. Global Digital Insomnia Therapeutics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Medical Major Player Table 8. Household Major Player Table 9. Digital Insomnia Therapeutics Industry Trends Table 10. Digital Insomnia Therapeutics Industry Drivers Table 11. Digital Insomnia Therapeutics Industry Opportunities and Challenges Table 12. Digital Insomnia Therapeutics Industry Restraints Table 13. Global Digital Insomnia Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Digital Insomnia Therapeutics Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Digital Insomnia Therapeutics Market Share by Region (2021-2026) Table 16. Global Digital Insomnia Therapeutics Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Digital Insomnia Therapeutics Market Share by Region (2027-2032) Table 18. Global Digital Insomnia Therapeutics Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Digital Insomnia Therapeutics Revenue Market Share by Players (2021-2026) Table 20. Global Digital Insomnia Therapeutics Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Digital Insomnia Therapeutics Key Players Headquarters & Area Served Table 22. Global Digital Insomnia Therapeutics Players, Product Type & Application Table 23. Global Digital Insomnia Therapeutics Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Digital Insomnia Therapeutics by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Digital Insomnia Therapeutics Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Digital Insomnia Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Digital Insomnia Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Digital Insomnia Therapeutics Revenue Market Share by Type (2021-2026) Table 30. Global Digital Insomnia Therapeutics Revenue Market Share by Type (2027-2032) Table 31. Global Digital Insomnia Therapeutics Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Digital Insomnia Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Digital Insomnia Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Digital Insomnia Therapeutics Revenue Market Share by Application (2021-2026) Table 35. Global Digital Insomnia Therapeutics Revenue Market Share by Application (2027-2032) Table 36. Headspace Inc Company Information Table 37. Headspace Inc Business Overview Table 38. Headspace Inc Digital Insomnia Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Headspace Inc Digital Insomnia Therapeutics Product Portfolio Table 40. Headspace Inc Recent Development Table 41. Big Health Company Information Table 42. Big Health Business Overview Table 43. Big Health Digital Insomnia Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Big Health Digital Insomnia Therapeutics Product Portfolio Table 45. Big Health Recent Development Table 46. Calm Company Information Table 47. Calm Business Overview Table 48. Calm Digital Insomnia Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Calm Digital Insomnia Therapeutics Product Portfolio Table 50. Calm Recent Development Table 51. Nox Health Company Information Table 52. Nox Health Business Overview Table 53. Nox Health Digital Insomnia Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Nox Health Digital Insomnia Therapeutics Product Portfolio Table 55. Nox Health Recent Development Table 56. Pear Therapeutics Company Information Table 57. Pear Therapeutics Business Overview Table 58. Pear Therapeutics Digital Insomnia Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Pear Therapeutics Digital Insomnia Therapeutics Product Portfolio Table 60. Pear Therapeutics Recent Development Table 61. OPTT Inc Company Information Table 62. OPTT Inc Business Overview Table 63. OPTT Inc Digital Insomnia Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. OPTT Inc Digital Insomnia Therapeutics Product Portfolio Table 65. OPTT Inc Recent Development Table 66. SilverCloud Company Information Table 67. SilverCloud Business Overview Table 68. SilverCloud Digital Insomnia Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. SilverCloud Digital Insomnia Therapeutics Product Portfolio Table 70. SilverCloud Recent Development Table 71. Curv Health Company Information Table 72. Curv Health Business Overview Table 73. Curv Health Digital Insomnia Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Curv Health Digital Insomnia Therapeutics Product Portfolio Table 75. Curv Health Recent Development Table 76. Bodymatter Inc Company Information Table 77. Bodymatter Inc Business Overview Table 78. Bodymatter Inc Digital Insomnia Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Bodymatter Inc Digital Insomnia Therapeutics Product Portfolio Table 80. Bodymatter Inc Recent Development Table 81. PrimeNap Company Information Table 82. PrimeNap Business Overview Table 83. PrimeNap Digital Insomnia Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. PrimeNap Digital Insomnia Therapeutics Product Portfolio Table 85. PrimeNap Recent Development Table 86. North America Digital Insomnia Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 87. North America Digital Insomnia Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 88. North America Digital Insomnia Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 89. North America Digital Insomnia Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 90. North America Digital Insomnia Therapeutics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 91. North America Digital Insomnia Therapeutics Revenue by Country (2021-2026) & (US$ Million) Table 92. North America Digital Insomnia Therapeutics Revenue by Country (US$ Million) & (2027-2032) Table 93. Europe Digital Insomnia Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 94. Europe Digital Insomnia Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 95. Europe Digital Insomnia Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 96. Europe Digital Insomnia Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 97. Europe Digital Insomnia Therapeutics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 98. Europe Digital Insomnia Therapeutics Revenue by Country (2021-2026) & (US$ Million) Table 99. Europe Digital Insomnia Therapeutics Revenue by Country (US$ Million) & (2027-2032) Table 100. China Digital Insomnia Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 101. China Digital Insomnia Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 102. China Digital Insomnia Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 103. China Digital Insomnia Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 104. Asia Digital Insomnia Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 105. Asia Digital Insomnia Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 106. Asia Digital Insomnia Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 107. Asia Digital Insomnia Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 108. Asia Digital Insomnia Therapeutics Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 109. Asia Digital Insomnia Therapeutics Revenue by Region (US$ Million) & (2021-2026) Table 110. Asia Digital Insomnia Therapeutics Revenue by Region (US$ Million) & (2027-2032) Table 111. SAMEA Digital Insomnia Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 112. SAMEA Digital Insomnia Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 113. SAMEA Digital Insomnia Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 114. SAMEA Digital Insomnia Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 115. SAMEA Digital Insomnia Therapeutics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. SAMEA Digital Insomnia Therapeutics Revenue by Country (2021-2026) & (US$ Million) Table 117. SAMEA Digital Insomnia Therapeutics Revenue by Country (US$ Million) & (2027-2032) Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Digital Insomnia Therapeutics Image Figure 2. Global Digital Insomnia Therapeutics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Digital Insomnia Therapeutics Market Size Share 2021 VS 2025 VS 2032 Figure 4. Sleep Tracking App Image Figure 5. Relaxation and Meditation Apps Image Figure 6. CBT-I Image Figure 7. Others Image Figure 8. Global Digital Insomnia Therapeutics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Digital Insomnia Therapeutics Market Size Share 2021 VS 2025 VS 2032 Figure 10. Medical Image Figure 11. Household Image Figure 12. Global Digital Insomnia Therapeutics Market Size (US$ Million) & (2021-2032) Figure 13. Global Digital Insomnia Therapeutics Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Digital Insomnia Therapeutics Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Digital Insomnia Therapeutics Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Digital Insomnia Therapeutics Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Digital Insomnia Therapeutics Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Digital Insomnia Therapeutics Revenue Market Share by Type (2021-2032) Figure 20. Global Digital Insomnia Therapeutics Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Digital Insomnia Therapeutics Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Digital Insomnia Therapeutics Revenue Market Share by Application (2021-2032) Figure 23. North America Digital Insomnia Therapeutics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Digital Insomnia Therapeutics Revenue Share by Type (2021-2032) Figure 25. North America Digital Insomnia Therapeutics Revenue Share by Application (2021-2032) Figure 26. North America Digital Insomnia Therapeutics Revenue Share by Country (2021-2032) Figure 27. United States Digital Insomnia Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Digital Insomnia Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Digital Insomnia Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Digital Insomnia Therapeutics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Digital Insomnia Therapeutics Revenue Share by Type (2021-2032) Figure 32. Europe Digital Insomnia Therapeutics Revenue Share by Application (2021-2032) Figure 33. Europe Digital Insomnia Therapeutics Revenue Share by Country (2021-2032) Figure 34. Germany Digital Insomnia Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Digital Insomnia Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Digital Insomnia Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Digital Insomnia Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Digital Insomnia Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Digital Insomnia Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Digital Insomnia Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Digital Insomnia Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Digital Insomnia Therapeutics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Digital Insomnia Therapeutics Revenue Share by Type (2021-2032) Figure 44. China Digital Insomnia Therapeutics Revenue Share by Application (2021-2032) Figure 45. Asia Digital Insomnia Therapeutics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Digital Insomnia Therapeutics Revenue Share by Type (2021-2032) Figure 47. Asia Digital Insomnia Therapeutics Revenue Share by Application (2021-2032) Figure 48. Asia Digital Insomnia Therapeutics Revenue Share by Region (2021-2032) Figure 49. Japan Digital Insomnia Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Digital Insomnia Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Digital Insomnia Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Digital Insomnia Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Digital Insomnia Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Digital Insomnia Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Digital Insomnia Therapeutics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Digital Insomnia Therapeutics Revenue Share by Type (2021-2032) Figure 57. SAMEA Digital Insomnia Therapeutics Revenue Share by Application (2021-2032) Figure 58. SAMEA Digital Insomnia Therapeutics Revenue Share by Country (2021-2032) Figure 59. Brazil Digital Insomnia Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Digital Insomnia Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Digital Insomnia Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Digital Insomnia Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Digital Insomnia Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Digital Insomnia Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Digital Insomnia Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Digital Insomnia Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Digital Insomnia Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Digital Insomnia Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Digital Insomnia Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Sleep Tracking App
  • Relaxation and Meditation Apps
  • CBT-I
  • Others
Applications
  • Medical
  • Household
Companies covered
  • Headspace Inc
  • Big Health
  • Calm
  • Nox Health
  • Pear Therapeutics
  • OPTT Inc
  • SilverCloud
  • Curv Health
  • Bodymatter Inc
  • PrimeNap

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Digital Insomnia Therapeutics Market by Type
  3. 1.2.1 Global Digital Insomnia Therapeutics Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Sleep Tracking App
  5. 1.2.3 Relaxation and Meditation Apps
  6. 1.2.4 CBT-I
  7. 1.2.5 Others
  8. 1.3 Digital Insomnia Therapeutics Market by Application
  9. 1.3.1 Global Digital Insomnia Therapeutics Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Medical
  11. 1.3.3 Household
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Digital Insomnia Therapeutics Market Dynamics
  1. 2.1 Digital Insomnia Therapeutics Industry Trends
  2. 2.2 Digital Insomnia Therapeutics Industry Drivers
  3. 2.3 Digital Insomnia Therapeutics Industry Opportunities and Challenges
  4. 2.4 Digital Insomnia Therapeutics Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Digital Insomnia Therapeutics Market Perspective (2021-2032)
  2. 3.2 Global Digital Insomnia Therapeutics Growth Trends by Region
  3. 3.2.1 Global Digital Insomnia Therapeutics Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Digital Insomnia Therapeutics Market Size by Region (2021-2026)
  5. 3.2.3 Global Digital Insomnia Therapeutics Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Digital Insomnia Therapeutics Revenue by Players
  2. 4.1.1 Global Digital Insomnia Therapeutics Revenue by Players (2021-2026)
  3. 4.1.2 Global Digital Insomnia Therapeutics Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Digital Insomnia Therapeutics Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Digital Insomnia Therapeutics Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Digital Insomnia Therapeutics Key Players Headquarters & Area Served
  7. 4.4 Global Digital Insomnia Therapeutics Players, Product Type & Application
  8. 4.5 Global Digital Insomnia Therapeutics Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Digital Insomnia Therapeutics Market CR5 and HHI
  11. 4.6.3 2025 Digital Insomnia Therapeutics Tier 1, Tier 2, and Tier 3
5 Digital Insomnia Therapeutics Market Size by Type
  1. 5.1 Global Digital Insomnia Therapeutics Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Digital Insomnia Therapeutics Revenue by Type (2021-2032)
  3. 5.3 Global Digital Insomnia Therapeutics Revenue Market Share by Type (2021-2032)
6 Digital Insomnia Therapeutics Market Size by Application
  1. 6.1 Global Digital Insomnia Therapeutics Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Digital Insomnia Therapeutics Revenue by Application (2021-2032)
  3. 6.3 Global Digital Insomnia Therapeutics Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Headspace Inc
  2. 7.1.1 Headspace Inc Company Information
  3. 7.1.2 Headspace Inc Business Overview
  4. 7.1.3 Headspace Inc Digital Insomnia Therapeutics Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Headspace Inc Digital Insomnia Therapeutics Product Portfolio
  6. 7.1.5 Headspace Inc Recent Developments
  7. 7.2 Big Health
  8. 7.2.1 Big Health Company Information
  9. 7.2.2 Big Health Business Overview
  10. 7.2.3 Big Health Digital Insomnia Therapeutics Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Big Health Digital Insomnia Therapeutics Product Portfolio
  12. 7.2.5 Big Health Recent Developments
  13. 7.3 Calm
  14. 7.3.1 Calm Company Information
  15. 7.3.2 Calm Business Overview
  16. 7.3.3 Calm Digital Insomnia Therapeutics Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Calm Digital Insomnia Therapeutics Product Portfolio
  18. 7.3.5 Calm Recent Developments
  19. 7.4 Nox Health
  20. 7.4.1 Nox Health Company Information
  21. 7.4.2 Nox Health Business Overview
  22. 7.4.3 Nox Health Digital Insomnia Therapeutics Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Nox Health Digital Insomnia Therapeutics Product Portfolio
  24. 7.4.5 Nox Health Recent Developments
  25. 7.5 Pear Therapeutics
  26. 7.5.1 Pear Therapeutics Company Information
  27. 7.5.2 Pear Therapeutics Business Overview
  28. 7.5.3 Pear Therapeutics Digital Insomnia Therapeutics Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Pear Therapeutics Digital Insomnia Therapeutics Product Portfolio
  30. 7.5.5 Pear Therapeutics Recent Developments
  31. 7.6 OPTT Inc
  32. 7.6.1 OPTT Inc Company Information
  33. 7.6.2 OPTT Inc Business Overview
  34. 7.6.3 OPTT Inc Digital Insomnia Therapeutics Revenue and Gross Margin (2021-2026)
  35. 7.6.4 OPTT Inc Digital Insomnia Therapeutics Product Portfolio
  36. 7.6.5 OPTT Inc Recent Developments
  37. 7.7 SilverCloud
  38. 7.7.1 SilverCloud Company Information
  39. 7.7.2 SilverCloud Business Overview
  40. 7.7.3 SilverCloud Digital Insomnia Therapeutics Revenue and Gross Margin (2021-2026)
  41. 7.7.4 SilverCloud Digital Insomnia Therapeutics Product Portfolio
  42. 7.7.5 SilverCloud Recent Developments
  43. 7.8 Curv Health
  44. 7.8.1 Curv Health Company Information
  45. 7.8.2 Curv Health Business Overview
  46. 7.8.3 Curv Health Digital Insomnia Therapeutics Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Curv Health Digital Insomnia Therapeutics Product Portfolio
  48. 7.8.5 Curv Health Recent Developments
  49. 7.9 Bodymatter Inc
  50. 7.9.1 Bodymatter Inc Company Information
  51. 7.9.2 Bodymatter Inc Business Overview
  52. 7.9.3 Bodymatter Inc Digital Insomnia Therapeutics Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Bodymatter Inc Digital Insomnia Therapeutics Product Portfolio
  54. 7.9.5 Bodymatter Inc Recent Developments
  55. 7.10 PrimeNap
  56. 7.10.1 PrimeNap Company Information
  57. 7.10.2 PrimeNap Business Overview
  58. 7.10.3 PrimeNap Digital Insomnia Therapeutics Revenue and Gross Margin (2021-2026)
  59. 7.10.4 PrimeNap Digital Insomnia Therapeutics Product Portfolio
  60. 7.10.5 PrimeNap Recent Developments
8 North America
  1. 8.1 North America Digital Insomnia Therapeutics Revenue (2021-2032)
  2. 8.2 North America Digital Insomnia Therapeutics Revenue by Type (2021-2032)
  3. 8.2.1 North America Digital Insomnia Therapeutics Revenue by Type (2021-2026)
  4. 8.2.2 North America Digital Insomnia Therapeutics Revenue by Type (2027-2032)
  5. 8.3 North America Digital Insomnia Therapeutics Revenue Share by Type (2021-2032)
  6. 8.4 North America Digital Insomnia Therapeutics Revenue by Application (2021-2032)
  7. 8.4.1 North America Digital Insomnia Therapeutics Revenue by Application (2021-2026)
  8. 8.4.2 North America Digital Insomnia Therapeutics Revenue by Application (2027-2032)
  9. 8.5 North America Digital Insomnia Therapeutics Revenue Share by Application (2021-2032)
  10. 8.6 North America Digital Insomnia Therapeutics Revenue by Country
  11. 8.6.1 North America Digital Insomnia Therapeutics Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Digital Insomnia Therapeutics Revenue by Country (2021-2026)
  13. 8.6.3 North America Digital Insomnia Therapeutics Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Digital Insomnia Therapeutics Revenue (2021-2032)
  2. 9.2 Europe Digital Insomnia Therapeutics Revenue by Type (2021-2032)
  3. 9.2.1 Europe Digital Insomnia Therapeutics Revenue by Type (2021-2026)
  4. 9.2.2 Europe Digital Insomnia Therapeutics Revenue by Type (2027-2032)
  5. 9.3 Europe Digital Insomnia Therapeutics Revenue Share by Type (2021-2032)
  6. 9.4 Europe Digital Insomnia Therapeutics Revenue by Application (2021-2032)
  7. 9.4.1 Europe Digital Insomnia Therapeutics Revenue by Application (2021-2026)
  8. 9.4.2 Europe Digital Insomnia Therapeutics Revenue by Application (2027-2032)
  9. 9.5 Europe Digital Insomnia Therapeutics Revenue Share by Application (2021-2032)
  10. 9.6 Europe Digital Insomnia Therapeutics Revenue by Country
  11. 9.6.1 Europe Digital Insomnia Therapeutics Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Digital Insomnia Therapeutics Revenue by Country (2021-2026)
  13. 9.6.3 Europe Digital Insomnia Therapeutics Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Digital Insomnia Therapeutics Revenue (2021-2032)
  2. 10.2 China Digital Insomnia Therapeutics Revenue by Type (2021-2032)
  3. 10.2.1 China Digital Insomnia Therapeutics Revenue by Type (2021-2026)
  4. 10.2.2 China Digital Insomnia Therapeutics Revenue by Type (2027-2032)
  5. 10.3 China Digital Insomnia Therapeutics Revenue Share by Type (2021-2032)
  6. 10.4 China Digital Insomnia Therapeutics Revenue by Application (2021-2032)
  7. 10.4.1 China Digital Insomnia Therapeutics Revenue by Application (2021-2026)
  8. 10.4.2 China Digital Insomnia Therapeutics Revenue by Application (2027-2032)
  9. 10.5 China Digital Insomnia Therapeutics Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Digital Insomnia Therapeutics Revenue (2021-2032)
  2. 11.2 Asia Digital Insomnia Therapeutics Revenue by Type (2021-2032)
  3. 11.2.1 Asia Digital Insomnia Therapeutics Revenue by Type (2021-2026)
  4. 11.2.2 Asia Digital Insomnia Therapeutics Revenue by Type (2027-2032)
  5. 11.3 Asia Digital Insomnia Therapeutics Revenue Share by Type (2021-2032)
  6. 11.4 Asia Digital Insomnia Therapeutics Revenue by Application (2021-2032)
  7. 11.4.1 Asia Digital Insomnia Therapeutics Revenue by Application (2021-2026)
  8. 11.4.2 Asia Digital Insomnia Therapeutics Revenue by Application (2027-2032)
  9. 11.5 Asia Digital Insomnia Therapeutics Revenue Share by Application (2021-2032)
  10. 11.6 Asia Digital Insomnia Therapeutics Revenue by Country
  11. 11.6.1 Asia Digital Insomnia Therapeutics Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Digital Insomnia Therapeutics Revenue by Country (2021-2026)
  13. 11.6.3 Asia Digital Insomnia Therapeutics Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Digital Insomnia Therapeutics Revenue (2021-2032)
  2. 12.2 SAMEA Digital Insomnia Therapeutics Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Digital Insomnia Therapeutics Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Digital Insomnia Therapeutics Revenue by Type (2027-2032)
  5. 12.3 SAMEA Digital Insomnia Therapeutics Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Digital Insomnia Therapeutics Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Digital Insomnia Therapeutics Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Digital Insomnia Therapeutics Revenue by Application (2027-2032)
  9. 12.5 SAMEA Digital Insomnia Therapeutics Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Digital Insomnia Therapeutics Revenue by Country
  11. 12.6.1 SAMEA Digital Insomnia Therapeutics Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Digital Insomnia Therapeutics Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Digital Insomnia Therapeutics Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst